🎉 M&A multiples are live!
Check it out!

Public Comps and Valuation Multiples
for BioTech

Benchmark revenue and EBITDA valuation multiples for public comps like GSK, Johnson & Johnson, Novo Nordisk, Vertex Pharmaceuticals and Gilead Sciences.

BioTech

See analyst estimates and all valuation multiples for BioTech
Company EV EV/Revenue EV/EBITDA
$784B 15.9x 40.7x
$392B 4.4x 12.3x
$368B 6.4x 14.3x
$280B 6.3x 12.9x
$149B 6.2x 19.6x
$145B 5.1x 12.1x
$141B 3.0x 14.2x
$130B 2.7x 9.2x
$121B 10.7x 54.4x
$86.8B 2.1x 6.1x
$83.2B 5.5x 16.4x
$71.1B 7.7x 17.9x
$57.2B 1.1x 5.4x
$8.7B 2.7x 7.8x
$7.4B 9.8x 37.6x
$6.2B 8.3x n/a
$5.7B n/a n/a
$5.5B 12.5x 41.1x
$4.8B 5.8x 21.8x
$4.4B 179.1x -7.8x
$3.2B 14.1x -5949.8x
$1.8B 1.8x 9.0x
$1.6B 1.4x 4.4x
$1.6B 36.3x -3.6x
$1.6B 2.4x 3.8x
$1.5B 622.7x -4.3x
$1.4B 1.7x 5.7x
$1.2B 1.0x 3.0x
$1.2B 1.9x 6.8x
$1.2B n/a n/a
$1.1B 109.5x -2.3x
$998M n/a -6.4x
$820M 2.8x 18.5x
$805M n/a n/a
$789M 19.4x -161.6x
$744M 2.2x 25.8x
$707M 1.0x 3.8x
$613M n/a n/a
$592M 1.3x 6.1x
$558M n/a n/a
$482M n/a -1.3x
$449M 6.4x n/a
$364M 9.8x -13.1x
$354M 1.1x 6.8x
$353M 65.1x n/a
$348M n/a n/a
$339M n/a -1.6x
$330M 7.0x -5.0x
$310M n/a -0.9x
$307M 29.7x -1.9x
$306M 1.2x 6.5x
$291M 43.9x -3.3x
$274M 1.3x -2.3x
$235M n/a n/a
$234M 108.5x -15.4x
$198M 0.5x 1.6x
$164M 1.2x -0.8x
$162M 13.8x n/a
$161M 2.6x -3.5x
$161M 5.7x -0.7x
$132M 1.3x 5.2x
$127M n/a -3.6x
$122M 197.2x -2.0x
$110M 90.5x -4.7x
$108M n/a -3.6x
$107M n/a n/a
$106M 0.9x 21.5x
$105M n/a n/a
$99.4M 171.2x n/a
$73.4M 2.6x n/a
$44.6M n/a n/a
$43.8M 5.5x n/a
$42.3M 8.4x -4.7x
$36.1M 1.4x n/a
$18.9M 4.9x n/a
$16.3M 20.2x -8.8x
$14.2M n/a n/a
$13.6M 8.2x n/a
$11.3M 22.3x n/a
$2.2M n/a -0.1x
-$3.3M -0.3x n/a
-$7.4M -0.4x n/a
-$15.5M -29.6x 0.3x
-$18.6M n/a n/a
-$24.4M n/a n/a
-$38.7M -0.3x -1.7x
-$44.5M n/a n/a
-$46.4M -2.0x n/a
-$51.6M n/a n/a
-$52.6M -2.9x n/a
-$72.1M -119.6x n/a
-$79.0M -43.7x 1.4x
-$96.6M n/a 0.6x
-$115M -11.8x 0.7x
-$220M n/a 0.8x
-$259M -216.0x 1.3x

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.